1. Home
  2. SYRE vs NVRI Comparison

SYRE vs NVRI Comparison

Compare SYRE & NVRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$33.85

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Enviri Corporation

NVRI

Enviri Corporation

HOLD

Current Price

$18.12

Market Cap

996.0M

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
SYRE
NVRI
Founded
2013
1853
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Diversified Commercial Services
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
996.0M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
SYRE
NVRI
Price
$33.85
$18.12
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$55.50
N/A
AVG Volume (30 Days)
652.6K
2.6M
Earning Date
11-04-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,244,061,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.72
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.91
$4.72
52 Week High
$34.54
$18.74

Technical Indicators

Market Signals
Indicator
SYRE
NVRI
Relative Strength Index (RSI) 78.25 80.47
Support Level $28.16 $18.13
Resistance Level $34.54 $18.47
Average True Range (ATR) 1.94 0.47
MACD 0.70 0.20
Stochastic Oscillator 92.54 89.18

Price Performance

Historical Comparison
SYRE
NVRI

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

About NVRI Enviri Corporation

Enviri Corp is a market-leading, provider of environmental solutions for industrial and specialty waste streams, and equipment and technology for the rail sector. The company's current operations consist of three divisions: Harsco Environmental, Harsco Rail, and Clean Earth. The company gains its revenue from Harsco Environmental segment. Geographically company operates in USA and International Countries, with majority revenue from USA.

Share on Social Networks: